IRLAB Therapeutics AB (publ) (STO:IRLAB.A)

IRLAB Therapeutics AB Statistics

Total Valuation

STO:IRLAB.A has a market cap or net worth of SEK 109.40 million. The enterprise value is 85.70 million.

Market Cap	109.40M
Enterprise Value	85.70M

Important Dates

The last earnings date was Wednesday, May 6, 2026.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:IRLAB.A has 84.94 million shares outstanding. The number of shares has increased by 43.64% in one year.

Current Share Class	84.86M
Shares Outstanding	84.94M
Shares Change (YoY)	+43.64%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	21.28%
Owned by Institutions (%)	30.18%
Float	56.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.18
PB Ratio	2.75
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.28
EV / Sales	0.93
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.68.

Current Ratio	0.88
Quick Ratio	0.88
Debt / Equity	0.68
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.76

Financial Efficiency

Return on equity (ROE) is -300.93% and return on invested capital (ROIC) is -48.93%.

Return on Equity (ROE)	-300.93%
Return on Assets (ROA)	-22.91%
Return on Invested Capital (ROIC)	-48.93%
Return on Capital Employed (ROCE)	-135.61%
Weighted Average Cost of Capital (WACC)	14.03%
Revenue Per Employee	2.98M
Profits Per Employee	-2.16M
Employee Count	31
Asset Turnover	0.63
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.36% in the last 52 weeks. The beta is 0.53, so STO:IRLAB.A's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-82.36%
50-Day Moving Average	1.47
200-Day Moving Average	2.15
Relative Strength Index (RSI)	41.38
Average Volume (20 Days)	203,955

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:IRLAB.A had revenue of SEK 92.46 million and -66.92 million in losses. Loss per share was -0.90.

Revenue	92.46M
Gross Profit	-4.45M
Operating Income	-54.03M
Pretax Income	-66.92M
Net Income	-66.92M
EBITDA	-49.79M
EBIT	-54.03M
Loss Per Share	-0.90

Balance Sheet

The company has 50.79 million in cash and 27.08 million in debt, with a net cash position of 23.70 million or 0.28 per share.

Cash & Cash Equivalents	50.79M
Total Debt	27.08M
Net Cash	23.70M
Net Cash Per Share	0.28
Equity (Book Value)	39.84M
Book Value Per Share	0.47
Working Capital	-11.45M

Cash Flow

Operating Cash Flow	-96.20M
Capital Expenditures	n/a
Depreciation & Amortization	4.28M
Net Borrowing	-14.41M
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is -4.81%, with operating and profit margins of -58.43% and -72.37%.

Gross Margin	-4.81%
Operating Margin	-58.43%
Pretax Margin	-72.37%
Profit Margin	-72.37%
EBITDA Margin	-53.85%
EBIT Margin	-58.43%
FCF Margin	n/a

Dividends & Yields

STO:IRLAB.A does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.64%
Shareholder Yield	-43.64%
Earnings Yield	-61.17%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 28, 2019. It was a forward split with a ratio of 5.

Last Split Date	May 28, 2019
Split Type	Forward
Split Ratio	5

Scores

STO:IRLAB.A has an Altman Z-Score of -7.16 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.16
Piotroski F-Score	2